Lyell Immunopharma prospectus covers resale of up to 7,428,040 shares
LYEL•A prospectus filed with the SEC covers the resale of up to 7,428,040 shares of Lyell Immunopharma common stock.
1. Resale prospectus
Lyell Immunopharma filed a prospectus covering the resale of up to 7,428,040 shares of its common stock.
